Cancer Treatment Holdings, Inc.
CTHZ
OTC PK
| 02/28/2003 | 11/30/2002 | 08/31/2002 | 05/31/2002 | 02/28/2002 | |
|---|---|---|---|---|---|
| Revenue | 43.00K | 65.70K | 55.80K | 58.80K | 74.30K |
| Total Other Revenue | -15.00K | -8.40K | -3.20K | 0.00 | -6.10K |
| Total Revenue | 28.10K | 50.80K | 46.00K | 52.20K | 61.60K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 28.10K | 50.80K | 46.00K | 52.20K | 61.60K |
| SG&A Expenses | 653.90K | 671.20K | 558.40K | 513.80K | 406.60K |
| Depreciation & Amortization | 18.80K | 18.80K | 18.80K | 18.80K | 18.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 672.70K | 690.00K | 577.20K | 532.60K | 425.40K |
| Operating Income | -644.70K | -639.30K | -531.10K | -480.30K | -363.70K |
| Income Before Tax | -1.04M | -602.70K | -485.90K | -443.70K | -327.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.04 | -0.60 | -0.49 | -0.44 | -0.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.04M | -602.70K | -485.90K | -443.70K | -327.50K |
| EBIT | -644.70K | -639.30K | -531.10K | -480.30K | -363.70K |
| EBITDA | -625.90K | -620.50K | -512.30K | -461.60K | -345.10K |
| EPS Basic | -0.31 | -0.18 | -0.15 | -0.13 | -0.10 |
| Normalized Basic EPS | -0.12 | -0.11 | -0.09 | -0.08 | -0.06 |
| EPS Diluted | -0.31 | -0.18 | -0.15 | -0.13 | -0.10 |
| Normalized Diluted EPS | -0.12 | -0.11 | -0.09 | -0.08 | -0.06 |
| Average Basic Shares Outstanding | 13.35M | 13.35M | 13.35M | 13.35M | 13.35M |
| Average Diluted Shares Outstanding | 13.35M | 13.35M | 13.35M | 13.35M | 13.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
